Key points from article :
Openwater, a medical technology company founded by former Google and Meta executive Mary Lou Jepsen, is aiming to revolutionize healthcare with its innovative, drug-free technology. Recently securing $54 million in new funding, Openwater has raised a total of $100 million to develop a platform that combines semiconductor physics, infrared imaging, ultrasound, and electromagnetic fields to diagnose and treat diseases at the cellular level. The company's approach allows for non-invasive monitoring and targeted therapies, offering the potential to destroy harmful cells while preserving healthy ones.
Openwater’s technology, which has been shown to shrink glioblastoma tumors in mice and treat severe depression in humans, works similarly to how specific sound frequencies can shatter a wine glass without affecting surrounding objects. By using open-source principles and leveraging consumer electronics manufacturing techniques, Openwater aims to reduce the costs and development time of medical devices dramatically, potentially bringing new products to market in under three years compared to the typical 13-year timeline.
The company has established partnerships with several prominent institutions, including UCLA, the University of Arizona, the University of Pennsylvania, and Brown University, to validate its platform across various medical fields. Investors such as Plum Alley Ventures, Khosla Ventures, and human rights activist Peter Gabriel, who helped name the company, believe that Openwater’s innovative approach could significantly lower healthcare costs and make advanced medical care accessible to everyone, everywhere.
